COMMUNIQUÉS West-GlobeNewswire

IBA – ACQUISITION OF OWN SHARES
01/06/2026
Louvain-la-Neuve, Belgium, June 1 st , 2026 – 9 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
01/06/2026
Louvain-la-Neuve, Belgique, 1 er juin 2026 – 21h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
01/06/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform designed to help [...]
Thought Leadership & Innovation Foundation Releases Whitepaper on CMS Medicare Advantage Final Rule and Announces Pilot Launch of Limb Outcomes Voice (LOV)
01/06/2026
New initiatives connect outcomes data, patient voice, and the future of value-based care in orthotics and prosthetics MCLEAN, Va., June 01, 2026 (GLOBE NEWSWIRE) -- To kick off a month-long celebration of the 15-year [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 22 - 2026
01/06/2026
Aggregated presentation by day and by market Purchases of own shares from May 25th to May 29th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 22 - 2026
01/06/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 25 mai au 29 mai 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
01/06/2026
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) -- J- [...]
Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
01/06/2026
Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL [...]
Origin Medical Announces Leadership Transition and Expands Executive Team Ahead of Commercial Launch
01/06/2026
CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Origin Medical, a pioneer in AI-powered ultrasound workflow solutions that improve access and support clinicians in delivering prenatal care, today announced a [...]
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
01/06/2026
Result of the payment of dividends in shares and record of the corresponding capital increase Paris, France (June 1, 2026) – The Annual General Meeting of EssilorLuxottica has decided to grant to the shareholders the [...]
EssilorLuxottica: Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante
01/06/2026
Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante Paris, France (1 er juin 2026) – L’Assemblée générale annuelle d’EssilorLuxottica a décidé de donner aux [...]
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
01/06/2026
LB2102 demonstrated a manageable safety profile and encouraging clinical activity in solid tumors among heavily pretreated patients Responses observed at higher dose levels of LB2102 with an ORR of 28.6% and a DCR of 78 [...]
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence
01/06/2026
The company introduces an expanded on-premise and hybrid C5ISR suite that enables local AI processing, command automation, and response coordination for defense, security, and critical infrastructure NETANYA, Israel, [...]
Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development
01/06/2026
SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS–based proteomics for research and pharmaceutical drug development. [...]
Ardena appoints Ariane de Ganck as Chief Scientific Officer
01/06/2026
Ghent, Belgium, June 1, 2026 - Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief [...]
Mapi Pharma to Participate in the ASCO Annual Meeting and ADA 2026 Scientific Sessions
01/06/2026
Company is seeking partnerships for the most advanced long-acting depot injections in its pipeline, including Anastrozole Depot and Semaglutide Depot NESS ZIONA, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd [...]
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
01/06/2026
Early results from solid tumor model support additional studies in pancreatic and colorectal cancer models; full dataset planned for presentation later in 2026 SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Oncolytics [...]
Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting
01/06/2026
- Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of three prospective Phase [...]
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
01/06/2026
Uniquely identified ~25% of the SLE patients who would otherwise be missed by conventional markers Demonstrated superior diagnostic accuracy compared with conventional testing, supporting earlier, more definitive [...]

Pages